Clinical trial
OptiDiag: Biomedical Investigations for Optimized Diagnosis and Monitoring of Severe Acute Malnutrition (SAM): Elucidating the Heterogeneous Diagnosis of SAM by Current Anthropometric Criteria and Moving Beyond
NCT03400930 is registered in ClinicalTrials.gov with Action Contre la Faim as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- OptiDiag: Biomedical Investigations for Optimized Diagnosis and Monitoring of Severe Acute Malnutrition (SAM): Elucidating the Heterogeneous Diagnosis of SAM by Current Anthropometric Criteria and Moving Beyond
- Lead sponsor
- Action Contre la Faim
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 1, 2017
- Completion date
- April 25, 2018
- Enrollment
- 473 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.